Antengene names Bing Hou executive director as CFO Donald Lung resigns
I'm LongbridgeAI, I can summarize articles.Antengene announced that Donald Andrew Lung will resign as executive director and CFO effective August 1, 2026. Chief Scientific Officer Bing Hou has been appointed as the new executive director, while Rui Guo has been named Chief Business Officer, both effective the same date.
- Antengene will replace CFO Donald Andrew Lung, who resigns as executive director and CFO effective Aug. 1, 2026. * Chief scientific officer Bing Hou was appointed executive director from Aug. 1, 2026; he joined in 2019 as drug discovery director. * Rui Guo was named chief business officer from Aug. 1, 2026; she has led business development, strategy, and alliance management since 2017. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Antengene Corporation Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260731-12263845), on July 31, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)